At a glance

What is palmitoyl pentapeptide-4?

Palmitoyl pentapeptide-4, often written pal-KTTKS, is a synthetic peptide designed as a topical skincare agent¹. Its active core, KTTKS, is a five amino acid sequence² (lysine-threonine-threonine-lysine-serine) taken from the propeptide of type I collagen. A palmitic acid chain is attached to that core to create the palmitoylated form, pal-KTTKS¹, which is the version used on skin.

It is sold as a cosmetic ingredient under trade names such as Matrixyl³, and it is included in serums and moisturizers for skin conditioning, smoothing, and anti-aging purposes³.

How does it work?

KTTKS is a fragment released when type I collagen is processed in the skin, and in laboratory studies, it stimulates fibroblasts² to produce type I collagen, type III collagen, and fibronectin, the main components of the skin's supportive matrix. Researchers proposed that this fragment acts as a feedback signal, with the released collagen piece prompting cells to make more matrix.

The plain KTTKS peptide is not well suited to topical use on its own, so a palmitic acid group is attached to create pal-KTTKS, the form developed as a topical agent¹ to stimulate collagen production for an anti-wrinkle benefit. Applied to the skin, it is used to support the appearance of firmer skin and reduce the look of fine lines and wrinkles¹.

Is palmitoyl pentapeptide-4 FDA-approved?

No, and it does not need to be. The FDA does not approve cosmetics or most cosmetic ingredients⁴ before they go on the market. Cosmetics are regulated and must be safe when used as directed and properly labeled, but there is no pre-market approval step the way there is for drugs, so no anti-aging peptide in a serum is "FDA-approved."

The line that actually matters for an ingredient like this is the difference between a cosmetic and a drug⁵. A product is a cosmetic when it is intended to improve appearance, but if it claims to change the structure or function of the skin, the FDA can regulate it as an unapproved drug⁵. This is why skincare claims are usually written around the appearance of the skin rather than a promised physiological change.

What is it used for?

Palmitoyl pentapeptide-4 is used almost entirely in topical anti-aging products, where it is included for skin conditioning, smoothing, and soothing³. In its main clinical study, it was tested for improving the appearance of fine lines and wrinkles¹ in photoaged facial skin.

What does the research show?

The main controlled evidence is a trial, and the rationale for its effect traces to earlier laboratory work.

The evidence base is real but limited:

• The key trial was conducted by researchers at Procter & Gamble¹.
• Sample sizes are small.
• There is little large, independent, or long-term data.

That supports a modest cosmetic benefit rather than a dramatic effect, which is why it sits at Moderate research on the evidence scale.

What are the side effects?

In its clinical study, pal-KTTKS was well tolerated by the skin¹. As with any skincare ingredient, some people can still experience mild redness, irritation, or an allergic reaction, so a patch test before regular use is sensible. Because the peptide is applied to the skin rather than injected, the safety considerations are those of a typical cosmetic ingredient.

More for skin & aging